Sen­a­tor ques­tions CVS, Wal­greens about growth in 340B par­tic­i­pa­tion

Sen. Bill Cas­sidy (R-LA), a rank­ing mem­ber on the Health, Ed­u­ca­tion, La­bor and Pen­sions Com­mit­tee, re­quest­ed in­for­ma­tion from CVS Health and Wal­greens Boots Al­liance about their roles as the largest phar­ma­cy par­tic­i­pants in the fed­er­al gov­ern­ment’s 340B pro­gram, which pro­vides out­pa­tient drugs at a dis­count to low-in­come pa­tients.

CVS is the largest con­tract phar­ma­cy par­tic­i­pant in the 340B pro­gram, ac­cord­ing to Cas­sidy’s let­ter, with Wal­greens fol­low­ing close­ly be­hind.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER